邁信林(688685.SH):2024年淨利潤4527.99萬元,同比增長197.01%
格隆匯2月26日丨邁信林(688685.SH)公佈2024年年度業績快報,報告期內,公司實現營業收入47,686.25萬元,同比增長62.38%;歸屬於母公司所有者的淨利潤4,527.99萬元,同比增長197.01%;歸屬於母公司所有者的扣除非經常性損益的淨利潤3,031.19萬元,同比增長190.00%。
在報告期內,公司對營銷策略進行了調整,並持續加大在新品研發方面的投入,實現了相關精密零部件業務的新客戶導入,不僅拓展了客戶資源,還使得原有存量客戶的業務量呈現出持續增長的良好態勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.